A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
Public ClinicalTrials.gov record NCT03924323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-Blind, Flexibly-dosed, Efficacy and Safety Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study in minors (7 to 17 years old) diagnosed with generalized anxiety disorder (GAD) and evaluated using standard questionnaires as having at least moderate severity of GAD. Participating minors will be assigned to receive either the study drug escitalopram or a pill without any drug in it called a placebo. The purpose of this research is to study the safety and effectiveness of escitalopram in minors with GAD.
Study identification
- NCT ID
- NCT03924323
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 273 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 7 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 30, 2019 (Actual)
- Primary completion
- Sep 20, 2021 (Actual)
- Completion
- Sep 20, 2021 (Actual)
- Last update posted
- Nov 14, 2022
2019 – 2021
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmonex /ID# 233342 | Dothan | Alabama | 36303 | — |
| Woodland International Research Group /ID# 233348 | Little Rock | Arkansas | 72211 | — |
| Woodland Research Northwest, LLC /ID# 233366 | Rogers | Arkansas | 72758-6442 | — |
| ATP Clinical Research, Inc /ID# 233362 | Costa Mesa | California | 92626-4607 | — |
| ProScience Research Group /ID# 233374 | Culver City | California | 90230-6632 | — |
| Sun Valley Research Center /ID# 233343 | Imperial | California | 92251-9401 | — |
| MCB Clinical Research Centers /ID# 233372 | Colorado Springs | Colorado | 80910 | — |
| Emerson Clinical Research Inst /ID# 233371 | Washington D.C. | District of Columbia | 20011 | — |
| Innovative Clinical Research /ID# 233365 | Fort Lauderdale | Florida | 33319 | — |
| Indago Research and Health Cen /ID# 233364 | Hialeah | Florida | 33012-4170 | — |
| CNS Healthcare - Jacksonville /ID# 233352 | Jacksonville | Florida | 32256-6039 | — |
| Accel Research Sites-Maitland Clinical Research Unit /ID# 233368 | Maitland | Florida | 32751 | — |
| Medical Research Group of Central Florida /ID# 233357 | Orange City | Florida | 32763 | — |
| Clinical Neuroscience Solutions, Inc /ID# 233350 | Orlando | Florida | 32801-2986 | — |
| APG Research, LLC /ID# 233337 | Orlando | Florida | 32803 | — |
| University of South Florida Rothman Center of Neuropsychiatry /ID# 233356 | St. Petersburg | Florida | 33701-4708 | — |
| Capstone Clinical Research /ID# 233354 | Libertyville | Illinois | 60048-5341 | — |
| Baber Research Group /ID# 233363 | Naperville | Illinois | 60563-6502 | — |
| Psychiatric Associates /ID# 233360 | Overland Park | Kansas | 66221 | — |
| Alivation Research /ID# 233338 | Lincoln | Nebraska | 68526-9474 | — |
| Center for Psychiatry and Behavioral Medicine Inc /ID# 233355 | Las Vegas | Nevada | 89128-0819 | — |
| Manhattan Behavioral Medicine PLLC /ID# 233351 | New York | New York | 10036 | — |
| Finger Lakes Clinical Research /ID# 233347 | Rochester | New York | 14618-1609 | — |
| Quest Therapeutics of Avon Lake /ID# 233367 | Avon Lake | Ohio | 44012 | — |
| Neuro-Behavioral Clinical Research, Inc. /ID# 233375 | Canton | Ohio | 44720 | — |
| University of Cincinnati /ID# 233341 | Cincinnati | Ohio | 45219 | — |
| UH Cleveland Medical Center /ID# 233373 | Cleveland | Ohio | 44106 | — |
| Midwest Clinical Research Center /ID# 233346 | Dayton | Ohio | 45417 | — |
| CincyScience /ID# 233359 | West Chester | Ohio | 45069 | — |
| SP Research, PLLC /ID# 233340 | Oklahoma City | Oklahoma | 73112-8729 | — |
| Central States Research /ID# 233339 | Tulsa | Oklahoma | 74136 | — |
| Coastal Carolina Research Center /ID# 233344 | North Charleston | South Carolina | 29405 | — |
| Houston Clinical Trials /ID# 233345 | Bellaire | Texas | 77401-2928 | — |
| Relaro Medical Trials /ID# 233369 | Dallas | Texas | 75243 | — |
| AIM Trials /ID# 233361 | Plano | Texas | 75093 | — |
| Focus Center, PC /ID# 233349 | Ogden | Utah | 84405-4946 | — |
| University of Virginia /ID# 233370 | Charlottesville | Virginia | 22903 | — |
| Northwest Clinical Research Center /ID# 233358 | Bellevue | Washington | 98007 | — |
| Core Clinical Research /ID# 233353 | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03924323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 14, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03924323 live on ClinicalTrials.gov.